
Tom Jefferson: Covid 19—many questions, no clear answers - The BMJ
Mar 2, 2020 · Because of my background as an epidemiologist and Cochrane researcher, and my involvement in the H1N1 outbreak, I often get stopped in the street, or in a bar, or the gym, and asked about covid-19. The questions are usually: how long does it take for the symptoms to manifest? How can I avoid it? Is it serious?
Tom Jefferson (epidemiologist) - Wikipedia
Tom Jefferson is a British epidemiologist, [1] based in Rome, Italy, [2] who works for the Cochrane Collaboration. Jefferson is an author and editor of the Cochrane Collaboration's acute respiratory infections group, as well as part of four other Cochrane groups. [3] .
Physical interventions to interrupt or reduce the spread of ... - The BMJ
Sep 22, 2009 · We carried out a systematic review to update our 2007 Cochrane review on the evidence of the effectiveness of public health measures such as isolation, distancing, and barriers to interrupt or reduce the spread of respiratory viruses.
Tom Jefferson: The UK turns to Witty, Vallance, and Van Tam ... - The BMJ
Dec 6, 2017 · Tom Jefferson, Senior Associate Tutor, University of Oxford. Competing interests: TJ was a recipient of a UK National Institute for Health Research grant for a Cochrane review of neuraminidase inhibitors for influenza. In addition, TJ receives royalties from his books published by Il Pensiero Scientifico Editore, Rome and Blackwells.
Cochrane reviewer sues Roche for claiming Tamiflu could slow ... - The BMJ
Jan 27, 2020 · Tom Jefferson, a frequent contributor to The BMJ, is suing as a private whistleblower for $1.5bn (£1.1bn; €1.4bn), roughly the amount that US public health authorities spent building up their pandemic stockpile of oseltamivir.
About - Tom Jefferson
Dr. Tom Jefferson is a Medically trained epidemiologist with extensive experience of HTA and handling huge datasets, including regulatory dossiers, clinical data synthesis, systematic reviews, health economics studies, meta-analysis within medical devices and pharmaceutical companies.
Dr. Tom Jefferson - Senior Clinical Tutor at University of Oxford
Dr. Tom Jefferson is a Senior Associate Tutor at the University of Oxford, a former researcher at the Nordic Cochrane Centre and a former scientific coordinator for the production of HTA reports on non-pharmaceuticals for Agenas, the Italian National Agency for Regional Healthcare.
PUBLICATIONS & REPORTS - Tom Jefferson
JEFFERSON TO, SMITH R, DRUMMOND MF, KALE R, YI Y, PRATT M.Evaluating the BMJ guidelines on economic submissions: prospective audit of economic submissions to the BMJ and Lancet. Paper presented at the Third International Congress on Peer Review in Biomedical Publication, Prague 18-20 September 1997. JEFFERSON TO, DEMICHELI V, HUTTON J.
Tom Jefferson: Covid-19—we live in surreal times - The BMJ
Mar 5, 2020 · Tom Jefferson is an an epidemiologist and Cochrane researcher, based in Rome, Italy. Competing interests: Please see full statement here.
Tom Jefferson Archives - The BMJ
Mar 5, 2020 · Tom Jefferson: Covid 19—many questions, no clear answers March 2, 2020 Because of my background as an epidemiologist and Cochrane researcher, and my involvement in the H1N1 outbreak, I often get stopped in the street, or in a bar, or the […]